Latest update on the condition of Rashford and Pedri

FC Barcelona

The English player completed the morning session and everything indicates that he will be available for Tuesday in London. Pedri's situation is different: he did not train with the group and will miss the match.

Days of speculation around Rashford: the club provided several versions regarding his absence, but the forward reappeared this Sunday and hopes to be included in the squad.

Rashford trained in the morning with the rest of the team and is expected to be available for the Tuesday match against Chelsea in London. The attacker had missed Thursday and Friday's training sessions with the group, and furthermore, he did not even go to Camp Nou on Saturday for the team's home debut against Athletic. The back and forth of explanations — personal matters, minor discomfort, fever process, and finally, a medical statement mentioning a flu process — raised doubts, but his presence on Sunday at the Ciutat Esportiva clears things up: he is likely to be in the lineup. Another story will be his starting role, with a Barcelona team where Ferran scored a brace against Athletic and Raphinha returns to the scene.

The mystery of the starting eleven

The big question is whether Rashford will start. Ferran's good form and Raphinha's return suggest caution. In any case, his participation is already a positive sign after a weekend of conflicting reports and absences.

Pedri, no chance for London

Pedri will not make it to the clash. The Canarian did not train with the group this Sunday, and his presence on Tuesday is completely ruled out. The midfielder suffered a hamstring injury in his left leg during the October 26 Clásico. With no official return date, a recovery time of around a month and a half was leaked, although the player managed to shorten the timeframe to the point of speculation about his comeback after the break. Caution prevails: the focus is on the Saturday match against Alavés — or at most, the one against Atlético de Madrid on December 2 —. If confirmed, it would advance the initial prognosis by about ten days.